Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 3
2010 3
2011 7
2012 3
2013 7
2014 2
2015 2
2016 10
2017 11
2018 9
2019 15
2020 17
2021 16
2022 14
2023 9
2024 12
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
An update on antiviral antibody-based biopharmaceuticals.
Ahangarzadeh S, Payandeh Z, Arezumand R, Shahzamani K, Yarian F, Alibakhshi A. Ahangarzadeh S, et al. Among authors: alibakhshi a. Int Immunopharmacol. 2020 Sep;86:106760. doi: 10.1016/j.intimp.2020.106760. Epub 2020 Jul 6. Int Immunopharmacol. 2020. PMID: 32645633 Free PMC article. Review.
Vaccine design and delivery approaches for COVID-19.
Shahzamani K, Mahmoudian F, Ahangarzadeh S, Ranjbar MM, Beikmohammadi L, Bahrami S, Mohammadi E, Esfandyari S, Alibakhshi A, Javanmard SH. Shahzamani K, et al. Among authors: alibakhshi a. Int Immunopharmacol. 2021 Nov;100:108086. doi: 10.1016/j.intimp.2021.108086. Epub 2021 Aug 23. Int Immunopharmacol. 2021. PMID: 34454291 Free PMC article. Review.
Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
Ranjbari J, Mokhtarzadeh A, Alibakhshi A, Tabarzad M, Hejazi M, Ramezani M. Ranjbari J, et al. Among authors: alibakhshi a. Curr Pharm Des. 2018 Feb 12;23(39):6019-6032. doi: 10.2174/1381612823666170505124927. Curr Pharm Des. 2018. PMID: 28482782 Review.
Targeted cancer therapy through antibody fragments-decorated nanomedicines.
Alibakhshi A, Abarghooi Kahaki F, Ahangarzadeh S, Yaghoobi H, Yarian F, Arezumand R, Ranjbari J, Mokhtarzadeh A, de la Guardia M. Alibakhshi A, et al. J Control Release. 2017 Dec 28;268:323-334. doi: 10.1016/j.jconrel.2017.10.036. Epub 2017 Nov 5. J Control Release. 2017. PMID: 29107128 Review.
Novel and emerging mutations of SARS-CoV-2: Biomedical implications.
Mohammadi E, Shafiee F, Shahzamani K, Ranjbar MM, Alibakhshi A, Ahangarzadeh S, Beikmohammadi L, Shariati L, Hooshmandi S, Ataei B, Javanmard SH. Mohammadi E, et al. Among authors: alibakhshi a. Biomed Pharmacother. 2021 Jul;139:111599. doi: 10.1016/j.biopha.2021.111599. Epub 2021 Apr 23. Biomed Pharmacother. 2021. PMID: 33915502 Free PMC article. Review.
Herbal Medicines as Potential Inhibitors of SARS-CoV-2 Infection.
Rostami S, Gharibi S, Yaghoobi H, Nokhodian Z, Shoaei P, Bahrami AA, Ahangarzadeh S, Alibakhshi A. Rostami S, et al. Among authors: alibakhshi a. Curr Pharm Des. 2022;28(29):2375-2386. doi: 10.2174/1381612828666220802121014. Curr Pharm Des. 2022. PMID: 35927924 Review.
Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers.
Arezumand R, Alibakhshi A, Ranjbari J, Ramazani A, Muyldermans S. Arezumand R, et al. Among authors: alibakhshi a. Front Immunol. 2017 Dec 8;8:1746. doi: 10.3389/fimmu.2017.01746. eCollection 2017. Front Immunol. 2017. PMID: 29276515 Free PMC article. Review.
138 results